Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115398416> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3115398416 abstract "Micronized purified flavonoid fraction (MPFF; Daflon®) containing 90% diosmin and 10% hesperidin is a vasoactive drug used for the treatment of chronic venous insufficiency and hemorrhoids. The aim of this study was to examine the effect of MPFF on the development of brain oxidative stress and neuronal damage induced in the rat by systemic rotenone injection. Rats received subcutaneous injections of rotenone (1.5 mg/kg) every other day for two weeks and were orally treated with MPFF (9 or 18 mg/kg). Results indicated that rotenone caused a significantly elevated oxidative stress in the cerebral cortex, striatum, and the rest of the brain tissue. Malondialdehyde (MDA) and nitric oxide concentrations were increased. In contrast, the level of reduced glutathione (GSH) and the activity of paraoxonase-1 (PON-1) were decreased in the above brain regions. Moreover, the concentration of the antiapoptotic protein B cell/lymphoma-2 (Bcl-2) in the striatum decreased after rotenone injection. Rotenone caused neuronal vacuolation and apoptotic neurons in the striatum, cortex, and hippocampus. Treatment with MPFF reduced, in a dose-dependent manner, the rotenone-induced increase in brain lipid peroxidation and nitric oxide and restored GSH level and PON-1 activity to vehicle control values. Moreover, MPFF was found to attenuate the decrease in Bcl-2 and the histopathological changes in the brain of rotenone-treated animals. These results suggest that MPFF could be a potential therapeutic “add on” for the pharmacological treatment of Parkinson’s disease." @default.
- W3115398416 created "2021-01-05" @default.
- W3115398416 creator A5028689490 @default.
- W3115398416 creator A5074160465 @default.
- W3115398416 creator A5075246930 @default.
- W3115398416 creator A5083649051 @default.
- W3115398416 date "2020-01-01" @default.
- W3115398416 modified "2023-09-27" @default.
- W3115398416 title "The Neuroprotective Effect of Micronized Purified Flavonoid Fraction in an Experimental Parkinson’s Disease Model" @default.
- W3115398416 doi "https://doi.org/10.20455/ros.2020.835" @default.
- W3115398416 hasPublicationYear "2020" @default.
- W3115398416 type Work @default.
- W3115398416 sameAs 3115398416 @default.
- W3115398416 citedByCount "0" @default.
- W3115398416 crossrefType "journal-article" @default.
- W3115398416 hasAuthorship W3115398416A5028689490 @default.
- W3115398416 hasAuthorship W3115398416A5074160465 @default.
- W3115398416 hasAuthorship W3115398416A5075246930 @default.
- W3115398416 hasAuthorship W3115398416A5083649051 @default.
- W3115398416 hasConcept C126322002 @default.
- W3115398416 hasConcept C134018914 @default.
- W3115398416 hasConcept C181199279 @default.
- W3115398416 hasConcept C185592680 @default.
- W3115398416 hasConcept C25498285 @default.
- W3115398416 hasConcept C2776151105 @default.
- W3115398416 hasConcept C2778004101 @default.
- W3115398416 hasConcept C2778389096 @default.
- W3115398416 hasConcept C2778401633 @default.
- W3115398416 hasConcept C2779054382 @default.
- W3115398416 hasConcept C2780062018 @default.
- W3115398416 hasConcept C2780565469 @default.
- W3115398416 hasConcept C28859421 @default.
- W3115398416 hasConcept C513476851 @default.
- W3115398416 hasConcept C538909803 @default.
- W3115398416 hasConcept C55493867 @default.
- W3115398416 hasConcept C71924100 @default.
- W3115398416 hasConcept C98274493 @default.
- W3115398416 hasConceptScore W3115398416C126322002 @default.
- W3115398416 hasConceptScore W3115398416C134018914 @default.
- W3115398416 hasConceptScore W3115398416C181199279 @default.
- W3115398416 hasConceptScore W3115398416C185592680 @default.
- W3115398416 hasConceptScore W3115398416C25498285 @default.
- W3115398416 hasConceptScore W3115398416C2776151105 @default.
- W3115398416 hasConceptScore W3115398416C2778004101 @default.
- W3115398416 hasConceptScore W3115398416C2778389096 @default.
- W3115398416 hasConceptScore W3115398416C2778401633 @default.
- W3115398416 hasConceptScore W3115398416C2779054382 @default.
- W3115398416 hasConceptScore W3115398416C2780062018 @default.
- W3115398416 hasConceptScore W3115398416C2780565469 @default.
- W3115398416 hasConceptScore W3115398416C28859421 @default.
- W3115398416 hasConceptScore W3115398416C513476851 @default.
- W3115398416 hasConceptScore W3115398416C538909803 @default.
- W3115398416 hasConceptScore W3115398416C55493867 @default.
- W3115398416 hasConceptScore W3115398416C71924100 @default.
- W3115398416 hasConceptScore W3115398416C98274493 @default.
- W3115398416 hasLocation W31153984161 @default.
- W3115398416 hasOpenAccess W3115398416 @default.
- W3115398416 hasPrimaryLocation W31153984161 @default.
- W3115398416 hasRelatedWork W13146187 @default.
- W3115398416 hasRelatedWork W20413612 @default.
- W3115398416 hasRelatedWork W20703465 @default.
- W3115398416 hasRelatedWork W21397074 @default.
- W3115398416 hasRelatedWork W22419451 @default.
- W3115398416 hasRelatedWork W27345388 @default.
- W3115398416 hasRelatedWork W8610565 @default.
- W3115398416 hasRelatedWork W8738251 @default.
- W3115398416 hasRelatedWork W914599 @default.
- W3115398416 hasRelatedWork W943077 @default.
- W3115398416 isParatext "false" @default.
- W3115398416 isRetracted "false" @default.
- W3115398416 magId "3115398416" @default.
- W3115398416 workType "article" @default.